Berlin-based e-health startup MediDate has acquired its rival, the Medical One clinic group, in a deal funded by the VC firm Earlybird, MediDate's largest investor. The price of the acquisition has not been disclosed.
Started as a digital intermediary in the sector of plastic and aesthetic surgery, the post-acquisition MediDate itself becomes a provider of medical services.
MediDate, which currently operates in Germany, Austria, and Switzerland, is planning further expansion in Europe and the US.
“With this acquisition, we are laying the foundation for our further accelerated growth strategy, said Sebastian Vohradnik, CEO and managing director of MediDate. “Our goal remains to make top-quality plastic and aesthetic medicine accessible to everyone. At the same time, we will continue to implement our internationalization efforts.”
MediDate takes on the task of digitalising the conservative and fragmented market of plastic and aesthetic surgery. Its product portfolio includes the areas of "non-invasive medicine" (filler, Botox), "weight" (gastric balloon), and "hair" (hair transplantation).
In the picture, left to right: MediDate founders Eiko Gerten, Sebastian Vohradnik, and Nico Kutschenko